Bupropion to aid smoking cessation
Relevant BNF section: 4.10
Around 1 in 4 adults in the UK smoke cigarettes and about two-thirds say they would like to give them up.1 However, giving up permanently is difficult, and each year, only about 2% of all smokers manage to do so.2,3 
Bupropion (Zyban - GlaxoWellcome) has recently been licensed "as an aid to smoking cessation in combination with motivational support". The manufacturer claims that there is evidence that the drug is "almost twice as effective as a nicotine patch in achieving smoking abstinence at one year". Here, we assess the efficacy and safety of bupropion in helping people stop smoking.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Cormac, I., Martin, D., Ferriter, M.
(2004). Improving the physical health of long-stay psychiatric in-patients. Adv. Psychiatr. Treat.
10: 107-115
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
